Common use of STATUS OF PRODUCTS AND APPROVALS Exhibit Clause in Contracts

STATUS OF PRODUCTS AND APPROVALS Exhibit. Q attached hereto lists all the products which are currently being marketed by Seller as well as all products which are currently under development by Seller. Said Exhibit Q further specifies those products which have, and those products which require or which might require, registration with or approval by the FDA (hereinafter "FDA Approval"). In the case of each such product which has FDA Approval, said FDA Approval is currently in full force and effect, and there is no basis for any adverse change in or withdrawal of such FDA Approval. In the case of those products which require or might require FDA Approval, where such Approval has not yet been obtained, said Exhibit Q specifies the expected schedule for obtaining said Approval. Except as listed on said Exhibit Q, there are no reasons to believe that the said Approvals will not be received substantially within such time frame. In the case of those products still under development, except as set forth on Exhibit Q, there are no material reasons to conclude that such products would not be viable in the United States and any other markets for which they are targeted. Exhibit Q also sets forth comparable information to that required above with respect to other countries where products are being marketed or are planned to be marketed, including providing information regarding any governmental approvals which exist and the status of any approvals which are being sought.